Pomerantz LLP is investigating claims against Evolus, Inc. following an FDA warning about misleading Instagram promotions for its wrinkle treatment Jeuveau. The FDA criticized the post for downplaying safety risks and making unsubstantiated claims about the product's effectiveness. After the warning was disclosed on October 2, 2026, Evolus's stock dropped 7.15%. The investigation may lead to a class action lawsuit concerning securities fraud or unlawful business practices by Evolus and its executives.
Evolus, Inc. faces an investigation following an FDA warning about its Instagram promotions, coinciding with a 7.15% stock drop. For readers following the health sector, here is Pluang's market snapshot as of Oct 28, 2026 05:02 WIB: Out of 150 priced US health stocks, 90 rose and 60 fell. Notable movers include SELLAS Life Sciences Group Inc. (SLS) up 7.32% at USD 12.17 with a typical hold time of 6 days, 10X Genomics Inc. (TXG) up 6.92% at USD 78.01 with 82% sell order activity and a 92-day hold time, and Novavax Inc. (NVAX) up 6.70% at USD 10.03 with 74% buy order activity and a 59-day hold time.
The global drone defense system market is projected to grow from $4.72 billion in 2025 to $18.19 billion by 2030, driven by increasing unauthorized drone incidents and demand for advanced detection and countermeasure technologies. Growth is fueled by...
Vallourec will publish its Q3 2026 financial results on November 20, 2026, at 07:30 AM CET. The company's CEO Philippe Guillemot and CFO Nathalie Delbreuve will present the results via a conference call and webcast at 09:30 AM CET the same day. Inves...
Clearfield, Inc. announced it will release its fiscal fourth quarter 2026 earnings on November 10, 2026, after market close. The company will hold a conference call at 5:00 p.m. Eastern time to discuss the results with investors. Financial details an...
Pomerantz LLP is investigating claims against Enova International and some of its executives for potential securities fraud following Enova's withdrawal of its application to acquire Grasshopper Bancorp, which would have made it a bank holding compan...
INVO Fertility, a healthcare company specializing in fertility clinics and technologies, will implement a 1-for-4 reverse stock split effective October 30, 2026. This means every 4 shares will be consolidated into 1 share, reducing the total shares o...
